INFLACAM ORAL SUSPENSION 1,5MG 15ML | ANTI-INFLAMMATORY FOR DOGS

INFLACAM 1,5 mg/ml Non-steroidal anti-inflammatory.

Laboratory
VIRBAC SPAIN, SA
Pharmaceutical form:
Oral suspension (Susp.o.)
Composition: per ml:
Meloxicam: 1,5 mg.
Pharmacological properties:
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam group that acts
inhibiting the synthesis of prostaglandins.
Interactions and incompatibilities:
• Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high
Protein affinity can compete for binding and produce toxic effects. Do not administer together
with other NSAIDs or glucocorticosteroids.
• In pre-treatment with anti-inflammatory substances, a free period of at least
24 hours.
Indications and target species:
Dogs: Relief of inflammation and pain in acute and chronic musculoskeletal disorders.
Contraindications:
• Do not use during pregnancy and lactation.
• Do not administer to dogs with gastrointestinal disorders such as irritation and bleeding, impaired
liver, heart or kidney function and bleeding disorders.
• Do not use in case of hypersensitivity to the active substance or to any of the excipients.
• Do not administer to dogs less than 6 weeks old.
Side effects:
• Infrequently: Loss of appetite, vomiting, diarrhea, fecal occult blood, lethargy and
renal insufficiency.
• In very rare cases: hemorrhagic diarrhoea, hematemesis, gastrointestinal ulceration and enzymes.
elevated hepatic
Route of administration:
Orally.
Posology:
Initial treatment: Single dose of 0,2 mg/kg on the first day. Continue with a dose of
maintenance of 0,1 mg meloxicam/kg (at 24 hour intervals).
• For long-term treatments, adjust to the minimum effective individual dose.
Special precautions:
Avoid its use in dehydrated, hypovolemic or hypotensive animals due to potential risk of
kidney toxicity.
Remarks:
With veterinary prescription.
Presentation:
15ml, 42ml and 100ml.
Reg No.:
EU/2/11/134/001 002 and 003

INFLACAM

DATA SHEET